ALIGN TECHNOLOGY INC (1ALGN.MI) Fundamental Analysis & Valuation

BIT:1ALGN • US0162551016

160.65 EUR
+5.65 (+3.65%)
Last: Feb 18, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This 1ALGN.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, 1ALGN scores 6 out of 10 in our fundamental rating. 1ALGN was compared to 65 industry peers in the Health Care Equipment & Supplies industry. 1ALGN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. 1ALGN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. 1ALGN.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ALGN was profitable.
  • 1ALGN had a positive operating cash flow in the past year.
  • 1ALGN had positive earnings in each of the past 5 years.
  • Of the past 5 years 1ALGN 4 years had a positive operating cash flow.
1ALGN.MI Yearly Net Income VS EBIT VS OCF VS FCF1ALGN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • 1ALGN has a Return On Assets of 6.07%. This is in the better half of the industry: 1ALGN outperforms 70.77% of its industry peers.
  • The Return On Equity of 1ALGN (9.57%) is better than 61.54% of its industry peers.
  • The Return On Invested Capital of 1ALGN (10.55%) is better than 81.54% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1ALGN is in line with the industry average of 10.72%.
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROIC 10.55%
ROA(3y)6.89%
ROA(5y)7.95%
ROE(3y)11.11%
ROE(5y)12.94%
ROIC(3y)10.68%
ROIC(5y)12.06%
1ALGN.MI Yearly ROA, ROE, ROIC1ALGN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • 1ALGN has a Profit Margin of 9.51%. This is in the better half of the industry: 1ALGN outperforms 69.23% of its industry peers.
  • In the last couple of years the Profit Margin of 1ALGN has declined.
  • With a decent Operating Margin value of 16.23%, 1ALGN is doing good in the industry, outperforming 70.77% of the companies in the same industry.
  • 1ALGN's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 69.48%, 1ALGN is doing good in the industry, outperforming 78.46% of the companies in the same industry.
  • In the last couple of years the Gross Margin of 1ALGN has remained more or less at the same level.
Industry RankSector Rank
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
OM growth 3Y-6.09%
OM growth 5Y-1.52%
PM growth 3Y1.65%
PM growth 5Y-32.36%
GM growth 3Y-1.6%
GM growth 5Y-1.19%
1ALGN.MI Yearly Profit, Operating, Gross Margins1ALGN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. 1ALGN.MI Health Analysis

2.1 Basic Checks

  • 1ALGN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1ALGN has less shares outstanding
  • 1ALGN has less shares outstanding than it did 5 years ago.
  • 1ALGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ALGN.MI Yearly Shares Outstanding1ALGN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
1ALGN.MI Yearly Total Debt VS Total Assets1ALGN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 5.22 indicates that 1ALGN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of 1ALGN (5.22) is better than 86.15% of its industry peers.
  • There is no outstanding debt for 1ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.22
ROIC/WACC1.07
WACC9.88%
1ALGN.MI Yearly LT Debt VS Equity VS FCF1ALGN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that 1ALGN should not have too much problems paying its short term obligations.
  • 1ALGN's Current ratio of 1.29 is on the low side compared to the rest of the industry. 1ALGN is outperformed by 66.15% of its industry peers.
  • A Quick Ratio of 1.17 indicates that 1ALGN should not have too much problems paying its short term obligations.
  • 1ALGN's Quick ratio of 1.17 is in line compared to the rest of the industry. 1ALGN outperforms 47.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.17
1ALGN.MI Yearly Current Assets VS Current Liabilites1ALGN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1ALGN.MI Growth Analysis

3.1 Past

  • 1ALGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.63%, which is quite good.
  • Measured over the past years, 1ALGN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.96% on average per year.
  • The Revenue has been growing slightly by 0.90% in the past year.
  • 1ALGN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.30% yearly.
EPS 1Y (TTM)12.63%
EPS 3Y13.37%
EPS 5Y14.96%
EPS Q2Q%34.84%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y2.61%
Revenue growth 5Y10.3%
Sales Q2Q%5.26%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.71% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1ALGN will show a small growth in Revenue. The Revenue will grow by 6.24% on average per year.
EPS Next Y6.49%
EPS Next 2Y7.51%
EPS Next 3Y9%
EPS Next 5Y10.71%
Revenue Next Year4.12%
Revenue Next 2Y4.32%
Revenue Next 3Y5.02%
Revenue Next 5Y6.24%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1ALGN.MI Yearly Revenue VS Estimates1ALGN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
1ALGN.MI Yearly EPS VS Estimates1ALGN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

5

4. 1ALGN.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1ALGN is valuated rather expensively with a Price/Earnings ratio of 18.03.
  • Based on the Price/Earnings ratio, 1ALGN is valued cheaper than 81.54% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of 1ALGN to the average of the S&P500 Index (26.46), we can say 1ALGN is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 16.93, which indicates a correct valuation of 1ALGN.
  • 1ALGN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1ALGN is cheaper than 66.15% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1ALGN to the average of the S&P500 Index (24.65), we can say 1ALGN is valued slightly cheaper.
Industry RankSector Rank
PE 18.03
Fwd PE 16.93
1ALGN.MI Price Earnings VS Forward Price Earnings1ALGN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 1ALGN's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ALGN indicates a somewhat cheap valuation: 1ALGN is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.02
EV/EBITDA 16.33
1ALGN.MI Per share data1ALGN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ALGN does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of 1ALGN may justify a higher PE ratio.
PEG (NY)2.78
PEG (5Y)1.21
EPS Next 2Y7.51%
EPS Next 3Y9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ALGN.MI Dividend Analysis

5.1 Amount

  • 1ALGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ALGN.MI Fundamentals: All Metrics, Ratios and Statistics

ALIGN TECHNOLOGY INC

BIT:1ALGN (2/18/2026, 7:00:00 PM)

160.65

+5.65 (+3.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners97.78%
Inst Owner ChangeN/A
Ins Owners0.69%
Ins Owner ChangeN/A
Market Cap11.53B
Revenue(TTM)4.03B
Net Income(TTM)378.59M
Analysts77.5
Price Target170.39 (6.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.79%
Min EPS beat(2)-4.95%
Max EPS beat(2)6.53%
EPS beat(4)2
Avg EPS beat(4)1.18%
Min EPS beat(4)-4.95%
Max EPS beat(4)6.53%
EPS beat(8)5
Avg EPS beat(8)2.84%
EPS beat(12)8
Avg EPS beat(12)3.11%
EPS beat(16)9
Avg EPS beat(16)-1.08%
Revenue beat(2)0
Avg Revenue beat(2)-3.18%
Min Revenue beat(2)-6.34%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-6.34%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.81%
Revenue beat(12)3
Avg Revenue beat(12)-1.6%
Revenue beat(16)3
Avg Revenue beat(16)-2.32%
PT rev (1m)6.41%
PT rev (3m)N/A
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)-2.22%
EPS NY rev (1m)0.35%
EPS NY rev (3m)1.77%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 18.03
Fwd PE 16.93
P/S 3.42
P/FCF 24.02
P/OCF 20.74
P/B 3.44
P/tB 4.04
EV/EBITDA 16.33
EPS(TTM)8.91
EY5.55%
EPS(NY)9.49
Fwd EY5.91%
FCF(TTM)6.69
FCFY4.16%
OCF(TTM)7.75
OCFY4.82%
SpS47.02
BVpS46.72
TBVpS39.75
PEG (NY)2.78
PEG (5Y)1.21
Graham Number96.78
Profitability
Industry RankSector Rank
ROA 6.07%
ROE 9.57%
ROCE 15.14%
ROIC 10.55%
ROICexc 11.09%
ROICexgc 12.97%
OM 16.23%
PM (TTM) 9.51%
GM 69.48%
FCFM 14.22%
ROA(3y)6.89%
ROA(5y)7.95%
ROE(3y)11.11%
ROE(5y)12.94%
ROIC(3y)10.68%
ROIC(5y)12.06%
ROICexc(3y)12.11%
ROICexc(5y)15.06%
ROICexgc(3y)14.28%
ROICexgc(5y)18.05%
ROCE(3y)15.33%
ROCE(5y)17.31%
ROICexgc growth 3Y-5.05%
ROICexgc growth 5Y2.48%
ROICexc growth 3Y-5.64%
ROICexc growth 5Y3.62%
OM growth 3Y-6.09%
OM growth 5Y-1.52%
PM growth 3Y1.65%
PM growth 5Y-32.36%
GM growth 3Y-1.6%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 51.62%
Cap/Sales 2.25%
Interest Coverage 250
Cash Conversion 80.04%
Profit Quality 149.64%
Current Ratio 1.29
Quick Ratio 1.17
Altman-Z 5.22
F-Score7
WACC9.88%
ROIC/WACC1.07
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.63%
EPS 3Y13.37%
EPS 5Y14.96%
EPS Q2Q%34.84%
EPS Next Y6.49%
EPS Next 2Y7.51%
EPS Next 3Y9%
EPS Next 5Y10.71%
Revenue 1Y (TTM)0.9%
Revenue growth 3Y2.61%
Revenue growth 5Y10.3%
Sales Q2Q%5.26%
Revenue Next Year4.12%
Revenue Next 2Y4.32%
Revenue Next 3Y5.02%
Revenue Next 5Y6.24%
EBIT growth 1Y-4.86%
EBIT growth 3Y-3.64%
EBIT growth 5Y8.62%
EBIT Next Year28.19%
EBIT Next 3Y13.41%
EBIT Next 5Y12.86%
FCF growth 1Y52.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.5%
OCF growth 3YN/A
OCF growth 5YN/A

ALIGN TECHNOLOGY INC / 1ALGN.MI FAQ

What is the ChartMill fundamental rating of ALIGN TECHNOLOGY INC (1ALGN.MI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 1ALGN.MI.


Can you provide the valuation status for ALIGN TECHNOLOGY INC?

ChartMill assigns a valuation rating of 4 / 10 to ALIGN TECHNOLOGY INC (1ALGN.MI). This can be considered as Fairly Valued.


What is the profitability of 1ALGN stock?

ALIGN TECHNOLOGY INC (1ALGN.MI) has a profitability rating of 6 / 10.


Can you provide the financial health for 1ALGN stock?

The financial health rating of ALIGN TECHNOLOGY INC (1ALGN.MI) is 7 / 10.


Can you provide the expected EPS growth for 1ALGN stock?

The Earnings per Share (EPS) of ALIGN TECHNOLOGY INC (1ALGN.MI) is expected to grow by 6.49% in the next year.